Thomas Baker
Family Medicine · Westlake, LANPI 1952981250
Payments from drug & device makers
Across 75 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$171
- Corium, LLC$164
- AstraZeneca$109
- Abbott$100
- Exact Sciences$84
- Novo Nordisk$69
- plus $596 from 18 others
What the payments were for
- Food & beverage$1,293100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $171 |
| Corium, LLC | 9 | $164 |
| AstraZeneca | 6 | $109 |
| Abbott | 5 | $100 |
| Exact Sciences | 5 | $84 |
| Novo Nordisk | 4 | $69 |
| Astellas Pharma US Inc | 3 | $64 |
| Bayer | 3 | $62 |
| Boehringer Ingelheim | 3 | $52 |
| Lilly USA, LLC | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Novartis | 2 | $40 |
| Dexcom, Inc. | 2 | $37 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Johnson & Johnson | 1 | $22 |
| Amgen | 1 | $20 |
| Merck | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $15 |
How this compares
$1,293 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 24 | $21,096 |
| MounjaroTirzepatide | 14 | $14,995 |
| Gabapentin | 42 | $1,087 |
| Atorvastatin Calcium | 63 | $860 |
| Levetiracetam | 21 | $765 |
| Duloxetine Hcl | 18 | $654 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $404 |
| Amlodipine Besylate | 57 | $343 |
| Irbesartan | 11 | $332 |
| Bupropion XlBupropion Hcl | 23 | $219 |
| Pantoprazole Sodium | 31 | $205 |
| Levothyroxine Sodium | 14 | $201 |
| Quetiapine Fumarate | 15 | $180 |
| Losartan Potassium | 19 | $178 |
| Metformin Hcl ErMetformin Hcl | 22 | $178 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $46 | $36,09138 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Westlake
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
- William NaboursLake Charles$3M
- Ramon VargasKenner$2.1M
- Stephen JonesNew Orleans$513K
- Joshua WhatleyLake Charles$366K
- Richard JeansonneMandeville$362K
- Kristen ThomasNew Orleans$361K
- Clint WilsonBossier City$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.